Conduit Pharmaceuticals Inc. (CDT) Ownership
CDT ownership summary
as of October 17, 2026- Institutions
- 0.1% of shares outstanding
- Insiders
- 33.93% of shares outstanding
- Shares outstanding
- 1.1M
- Float
- 21K shares available to trade
- Short interest
- 3.43% 38K shares short
- Days to cover
- 0.10 short interest down 84.1% vs prior month
- Institutions 0.06%
- Insiders 33.93%
- Other investors 66.01%
CDT top institutional holders
6 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Financial Management Professionals Inc | 0.10% | 10K | $2,351 | +10,005 (0.0%) | June 30, 2026 |
| 2 | Tower Research Capital LLC | 0.09% | 9,095 | $2,137 | +8,985 (+8,168.2%) | June 30, 2026 |
| 3 | Apollon Wealth Management, LLC | 0.00% | — | — | −13,431 (−100.0%) | March 31, 2026 |
| 4 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −2 (−100.0%) | June 30, 2026 |
| 5 | SBI Securities Co Ltd | 0.00% | — | — | −2 (−100.0%) | March 31, 2026 |
| 6 | Virtu Financial LLC | 0.00% | — | — | −15,636 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 6, 2 holders added 19K shares and 4 cut 29K.
CDT top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.15% | 1,476 | $347 | — | August 31, 2026 |
| 2 | Fidelity Nasdaq Composite Index | 0.02% | 197 | $46 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CDT insider transactions
latest 10| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-10-07 | Ltd Nirland | Sell | $30,000.00 | 3 | $90,000 |
| 2024-10-04 | Ltd Nirland | Sell | $30,000.00 | 4 | $120,000 |
| 2024-10-02 | Ltd Nirland | Sell | $30,000.00 | 1 | $30,000 |
| 2024-09-30 | Ltd Nirland | Sell | $36,000.00 | 3 | $108,000 |
| 2024-07-17 | Andrew Regan | Sell | $78,000.00 | 5 | $390,000 |
| 2024-07-15 | Andrew Regan | Sell | $75,000.00 | 3 | $225,000 |
| 2024-07-12 | Andrew Regan | Sell | $75,000.00 | 4 | $300,000 |
| 2024-07-10 | Andrew Regan | Sell | $99,000.00 | — | — |
| 2024-07-08 | Andrew Regan | Sell | $153,000.00 | — | — |
| 2024-07-03 | Andrew Regan | Sell | $192,000.00 | — | — |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CDT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CDT
Institutional investors own 0.1% of Conduit Pharmaceuticals's shares and insiders 33.93%. The largest holder is Financial Management Professionals Inc with 0.10% of the shares (10K), as of June 30, 2026. Among the top 6 institutions, 2 added shares and 4 reduced their stake in the latest filings. Short interest is 3.43% of the float, or 0.10 days of average trading volume. The share count rose 307,033.3% since 2021.
Related: CDT key metrics. See the CDT stock overview for the latest quote and news.
CDT ownership FAQ
Who owns the most Conduit Pharmaceuticals stock?
The largest shareholders of Conduit Pharmaceuticals are Financial Management Professionals Inc (0.10%), Tower Research Capital LLC (0.09%), Apollon Wealth Management, LLC (0.00%), Morgan Stanley - Brokerage Accounts (0.00%), SBI Securities Co Ltd (0.00%).
What percentage of Conduit Pharmaceuticals is owned by institutions?
Institutions hold 0.1% of Conduit Pharmaceuticals's shares outstanding; insiders hold 33.93%.
Which funds own Conduit Pharmaceuticals?
The largest fund holders of Conduit Pharmaceuticals are Fidelity Extended Market Index (0.15%), Fidelity Nasdaq Composite Index (0.02%).
What is Conduit Pharmaceuticals's short interest?
38K shares of Conduit Pharmaceuticals were sold short, 3.43% of the float; at the average daily volume it would take 0.10 days to cover.
Are insiders buying or selling Conduit Pharmaceuticals?
Of the latest 10 reported insider transactions in Conduit Pharmaceuticals (since July 3, 2024), 0 were purchases and 10 were sales.
How many shares of Conduit Pharmaceuticals are outstanding?
Conduit Pharmaceuticals has 1.1M shares outstanding, of which 21K are in the public float.